Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.

<h4>Objective</h4>The factors associated with the development of immune reconstitution inflammatory syndrome in HIV patients commencing antiretroviral therapy have not been fully elucidated. Using a longitudinal study design, this study addressed whether alteration in the levels of T reg...

Full description

Saved in:
Bibliographic Details
Main Authors: Irfan Zaidi, Kevin Peterson, David Jeffries, Hilton Whittle, Thushan de Silva, Sarah Rowland-Jones, Assan Jaye, Bouke C de Jong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0039213&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<h4>Objective</h4>The factors associated with the development of immune reconstitution inflammatory syndrome in HIV patients commencing antiretroviral therapy have not been fully elucidated. Using a longitudinal study design, this study addressed whether alteration in the levels of T regulatory cells contributed to the development of IRIS in a West African cohort of HIV-1 and HIV-2 patients. Seventy-one HIV infected patients were prospectively recruited to the study and followed up for six months. The patients were categorized as IRIS or non-IRIS cases following published clinical guidelines. The levels of T regulatory cells were measured using flow cytometry at baseline and all follow-up visits. Baseline cytokine levels of IL-2, IL-6, IFN-γ, TNF-α, MIP-1β, IL-1, IL-12, IL-13, and IL-10 were measured in all patients.<h4>Results</h4>Twenty eight percent of patients (20/71) developed IRIS and were predominantly infected with HIV-1. Patients developing IRIS had lower nadir CD4 T cells at baseline (p = 0.03) and greater CD4 T cell reconstitution (p = 0.01) at six months post-ART. However, the development of IRIS was not influenced by the levels of T regulatory cells. Similarly, baseline cytokine levels did not predict the onset of IRIS.<h4>Conclusion</h4>The development of IRIS was not associated with differences in levels of T regulatory cells or baseline pro-inflammatory cytokines.
ISSN:1932-6203